Collegium Pharmaceutical
COLL
£22.68
Share price
1.81%
Change (1 day)
-8.89%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - Total debt
Total debt on the balance sheet as of March 2025 : £0.61 Billion
According to Collegium Pharmaceutical 's latest financial reports the company's total debt is £0.61 Billion. A company’s total debt is the sum of all current and non-current debts.
Collegium Pharmaceutical - Total debt on balance sheet (from 2014 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | £0.68 B | 29.38% |
| 2023-12-31 | £0.52 B | -9.71% |
| 2022-12-31 | £0.58 B | 205.8% |
| 2021-12-31 | £0.19 B | -1.99% |
| 2020-12-31 | £0.19 B | 1087.65% |
| 2019-12-31 | £16.46 M | 81.77% |
| 2018-12-31 | £9.05 M | 727.87% |
| 2017-12-31 | £1.09 M | -67.43% |
| 2016-12-31 | £3.36 M | -26.91% |
| 2015-12-31 | £4.59 M | -44.97% |
| 2014-12-31 | £8.35 M | 1316.31% |
| 2013-12-31 | £0.58 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Agile Therapeutics
AGRX | £0.21 M | -99.97% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | £1.87 B | 202.94% | 🇮🇪 Ireland |
 United Therapeutics UTHR | £0.14 B | -76.31% | 🇺🇸 USA |
 KemPharm KMPH | £16.96 M | -97.26% | 🇺🇸 USA |